G. Saletti

发表

Genomic Approach for Analysis of Surface Proteins in Chlamydia pneumoniae

R. Nogarotto, G. Grandi, R. Petracca, 2002, Infection and Immunity.

Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea

D. W. Kim, C. Czerkinsky, T. Ramamurthy, 2016, Clinical and Vaccine Immunology.

Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates

M. Houghton, G. Bensi, S. Coates, 2000, Journal of Virology.

Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood

C. Czerkinsky, J. Yang, G. Saletti, 2013, Nature Protocols.

DNA-Based Vaccine Candidates Secreted Recombinant Protein and Recombinant Protein Is Superior to Endoplasmic Reticulum-Retained Glycoprotein E 2 for Vaccine Design : an Evaluation of Hepatitis C Virus

M. Houghton, G. Bensi, G. Grandi, 2000 .

Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.

M. Houghton, V. Barnaba, E. De Gregorio, 2005, Proceedings of the National Academy of Sciences of the United States of America.

A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers.

C. Czerkinsky, N. Kim, M. Oh, 2010, Vaccine.

Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity

A. Winkel, G. Rimmelzwaan, A. Melk, 2022, Journal of Clinical Virology.

Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus

C. Czerkinsky, N. Molodecky, R. K. Nandy, 2016, PloS one.

Genomic Approach for Analysis of Surface Proteins in Chlamydia pneumoniae

R. Nogarotto, G. Grandi, R. Petracca, 2002, Infection and Immunity.

Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults

G. Rimmelzwaan, Rebecca Jonczyk, C. Blume, 2022, Nature Aging.

Recombinant influenza A viruses as vaccine vectors

G. Rimmelzwaan, T. Gerlach, G. Saletti, 2019, Expert review of vaccines.

Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant

G. Dougan, R. Rappuoli, M. Pizza, 1996, Infection and immunity.

Response Modifiers: Tweaking the Immune Response Against Influenza A Virus

G. Rimmelzwaan, T. Gerlach, G. Saletti, 2019, Front. Immunol..

Broadly protective influenza vaccines: design and production platforms.

G. Rimmelzwaan, T. Gerlach, G. Saletti, 2019, Current opinion in virology.

Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants

Wendy K. Jo, A. Osterhaus, T. Schulz, 2021, Proceedings of the National Academy of Sciences.

Aging and Options to Halt Declining Immunity to Virus Infections

A. Osterhaus, G. Rimmelzwaan, T. Becker, 2021, Frontiers in Immunology.

Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63

B. Bosch, A. Osterhaus, G. Rimmelzwaan, 2020, Scientific Reports.

Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis

V. Barnaba, S. Nuti, S. Abrignani, 1998, European journal of immunology.

Coligation of the Hepatitis C Virus Receptor CD81 with CD28 Primes Naive T Lymphocytes to Acquire Type 2 Effector Function1

A. Serra, S. Nuti, S. Abrignani, 2008, The Journal of Immunology.

Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination.

G. Rimmelzwaan, T. Gerlach, J. M. Jansen, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Influenza vaccines: 'tailor-made' or 'one fits all'.

G. Rimmelzwaan, T. Gerlach, G. Saletti, 2018, Current opinion in immunology.

Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection

G. Rimmelzwaan, K. Jung, C. K. Prajeeth, 2023, Frontiers in Immunology.

Lymphocytes to Acquire Type 2 Effector CD81 with CD28 Primes Naive T Coligation of the Hepatitis C Virus Receptor

S. Nuti, S. Abrignani, D. Rosa, 2013 .

Lack of Interference with Immunogenicity of a Chimeric Alphavirus Replicon Particle-Based Influenza Vaccine by Preexisting Antivector Immunity

R. Rappuoli, Y. Uematsu, C. Greer, 2012, Clinical and Vaccine Immunology.

alphavirus replicon particle-based influenza vaccine by pre-

R. Rappuoli, Y. Uematsu, C. Greer, 2012 .

Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections—an Open Observational Study in Lower Saxony, Germany

G. Rimmelzwaan, M. Stiesch, Rebecca Jonczyk, 2022, Microbiology spectrum.

MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination

U. Wernery, M. Rodríguez, A. Volz, 2023, Emerging infectious diseases.

Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level.

Marco Schiavon, Vincenzo Ciminale, Ferenc Follath, 2008, American journal of respiratory cell and molecular biology.

Selective pressure mediated by influenza virus M158–66 epitope-specific CD8+T cells promotes accumulation of extra-epitopic amino acid substitutions associated with viral resistance to these T cells

G. Rimmelzwaan, C. E. van de Sandt, G. Saletti, 2024, Virus research.

Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity

F. Strle, G. Rimmelzwaan, M. Korva, 2024, Emerging microbes & infections.